Literature DB >> 1978326

Labeling of epsilon-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase.

K N Parameswaran1, P T Velasco, J Wilson, L Lorand.   

Abstract

Peptides patterned on the N-terminal sequence of fibronectin were synthesized and tested for amine acceptor qualities in reactions with dansylcadaverine catalyzed either by coagulation factor XIIIa or intracellular transglutaminase (protein-glutamine:amine gamma-glutamyltransferase, EC 2.3.2.13). On the basis of inverse half-saturations of the enzymes, the order of acceptor substrate affinity for factor XIIIa was pEAQQIV much greater than Boc-AQQIV greater than Boc-QQIV, and for transglutaminase, Boc-QQIV greater than Boc-AQQIV greater than pEAQQIV (amino acid residues are shown in one-letter code; pE, pyroglutamic acid; Boc, tert-butyloxycarbonyl). Sequence analysis of dansylcadaverine-substituted pEAQQIV indicated that the first of the two adjacent glutamine residues was the target of enzymatic modification. Boc-QIV showed no substrate activity with either enzyme. Crosslinking of crystallins in Ca2(+)-treated rabbit lens homogenate was readily inhibited by Boc-QQIV, Boc-AQQIV, and pEAQQIV, as was the formation of alpha-chain polymers in human fibrin by pEAQQIV in the presence of human factor XIIIa. SDS/PAGE analysis suggested that the inhibitory peptides selectively blocked the electron donor functionalities in these enzymatic crosslinking reactions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978326      PMCID: PMC54978          DOI: 10.1073/pnas.87.21.8472

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  Human Factor XIII from plasma and platelets. Molecular weights, subunit structures, proteolytic activation, and cross-linking of fibrinogen and fibrin.

Authors:  M L Schwartz; S V Pizzo; R L Hill; P A McKee
Journal:  J Biol Chem       Date:  1973-02-25       Impact factor: 5.157

2.  Transamidating enzymes. I. Rapid chromatographic assays.

Authors:  L Lorand; L K Campbell
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

3.  Amine specificity in transpeptidation. Inhibition of fibrin cross-linking.

Authors:  L Lorand; N G Rule; H H Ong; R Furlanetto; A Jacobsen; J Downey; N Oner; J Bruner-Lorand
Journal:  Biochemistry       Date:  1968-03       Impact factor: 3.162

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  [A new method for synthesis of peptides: activation of the carboxyl group with dicyclohexylcarbodiimide using 1-hydroxybenzotriazoles as additives].

Authors:  W König; R Geiger
Journal:  Chem Ber       Date:  1970

6.  Formation of a 55 000-weight cross-linked beta crystallin dimer in the Ca2+-treated lens. A model for cataract.

Authors:  L Lorand; S M Conrad; P T Velasco
Journal:  Biochemistry       Date:  1985-03-12       Impact factor: 3.162

Review 7.  Transglutaminases.

Authors:  L Lorand; S M Conrad
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

8.  Partial primary structure of bovine plasma fibronectin: three types of internal homology.

Authors:  T E Petersen; H C Thøgersen; K Skorstengaard; K Vibe-Pedersen; P Sahl; L Sottrup-Jensen; S Magnusson
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

9.  Acceptor-donor relationships in the transglutaminase-mediated cross-linking of lens beta-crystallin subunits.

Authors:  P T Velasco; L Lorand
Journal:  Biochemistry       Date:  1987-07-28       Impact factor: 3.162

10.  Probing the transglutaminase-mediated, posttranslational modification of proteins during development.

Authors:  L Cariello; P T Velasco; J Wilson; K N Parameswaran; F Karush; L Lorand
Journal:  Biochemistry       Date:  1990-05-29       Impact factor: 3.162

View more
  11 in total

1.  Expression and regulation of cornified envelope proteins in human corneal epithelium.

Authors:  Louis Tong; Rosa M Corrales; Zhuo Chen; Arturo L Villarreal; Cintia S De Paiva; Roger Beuerman; De-Quan Li; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

2.  Sorting-out of acceptor-donor relationships in the transglutaminase-catalyzed cross-linking of crystallins by the enzyme-directed labeling of potential sites.

Authors:  L Lorand; K N Parameswaran; P T Velasco
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-01       Impact factor: 11.205

3.  Reactivity of the N-terminal region of fibronectin protein to transglutaminase 2 and factor XIIIA.

Authors:  Brian R Hoffmann; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

4.  Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed cross-linking: relevance to diseases of the nervous system.

Authors:  P Kahlem; C Terré; H Green; P Djian
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Oligomeric and polymeric aggregates formed by proteins containing expanded polyglutamine.

Authors:  S Iuchi; G Hoffner; P Verbeke; P Djian; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

6.  Method for screening and MALDI-TOF MS sequencing of encoded combinatorial libraries.

Authors:  Bi-Huang Hu; Marsha Ritter Jones; Phillip B Messersmith
Journal:  Anal Chem       Date:  2007-08-23       Impact factor: 6.986

7.  Isolation of transglutaminase-reactive sequences from complex biological systems: a prominent lysine donor sequence in bovine lens.

Authors:  L Lorand; P T Velasco; S N Murthy; J Wilson; K N Parameswaran
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

8.  Exposure of beta H-crystallin to hydroxyl radicals enhances the transglutaminase-susceptibility of its existing amine-donor and amine-acceptor sites.

Authors:  P J Groenen; M Seccia; R H Smulders; E Gravela; K H Cheeseman; H Bloemendal; W W de Jong
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

9.  Inhibition of transglutaminase 2 mitigates transcriptional dysregulation in models of Huntington disease.

Authors:  Stephen J McConoughey; Manuela Basso; Zoya V Niatsetskaya; Sama F Sleiman; Natalia A Smirnova; Brett C Langley; Lata Mahishi; Arthur J L Cooper; Marc A Antonyak; Rick A Cerione; Bo Li; Anatoly Starkov; Rajnish Kumar Chaturvedi; M Flint Beal; Giovanni Coppola; Daniel H Geschwind; Hoon Ryu; Li Xia; Siiri E Iismaa; Judit Pallos; Ralf Pasternack; Martin Hils; Jing Fan; Lynn A Raymond; J Lawrence Marsh; Leslie M Thompson; Rajiv R Ratan
Journal:  EMBO Mol Med       Date:  2010-09       Impact factor: 12.137

10.  Secretory leukocyte protease inhibitor (SLPI) is, like its homologue trappin-2 (pre-elafin), a transglutaminase substrate.

Authors:  Kévin Baranger; Marie-Louise Zani; Valérie Labas; Sandrine Dallet-Choisy; Thierry Moreau
Journal:  PLoS One       Date:  2011-06-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.